LEVOHEARTSHOCK
Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. (LevoHeartShock)
![](https://inicrct.fr/wp-content/uploads/2021/01/cropped-cropped-cropped-LEVY.png)
Pr Bruno LEVY
Coordonnateur du projet LevoHeartShock
![](https://inicrct.fr/wp-content/uploads/2020/11/cropped-cropped-cropped-cropped-cropped-cropped-cropped-AdobeStock_383187927-1-1-6.jpeg)
![](https://inicrct.fr/wp-content/uploads/2020/06/cropped-cropped-cropped-cropped-cropped-cropped-cropped-cropped-chru1-1.jpg)
Promoteur : CHRU Nancy
![](https://inicrct.fr/wp-content/uploads/2021/01/cropped-Logo_CIC-P_2018-HD.png)